NOVAMIND KAT.CR UPDATE

The highest precision ensured by state of the art CNC machinery.

Excellent raw material (titanium grade 4) provided exclusively from the German company Zapp.

We offer a wide range of solutions and ideas that make implantology a profitable field easy to approach.įor the implants, we followed the same guidelines, such us: So due to the overwhelming demand for Novamind prosthetic parts, we decided to proceed with the development of implant systems. The high quality of the Novamind products has made them a market leader in implant prosthetics in several countries. Novamind has been using the state of the art technology in the production of the prosthetic components. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, ON / ACCESSWIRE / Janu/Novamind Inc. This fact guaranties the correct design and compatibility of Novamind implant systems. The company was founded by dental professionals with experience in implantology.

NOVAMIND KAT.CR UPDATE

The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws.Novamind is a manufacturer of implant prosthetic components for almost a decade.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

The reader is cautioned not to place undue reliance on any forward-looking information. Important factors that could cause actual results to differ materially from the Company's expectations including the risks detailed from time to time in the Company's public disclosure. With Novamind research company, which is among the most reliable research companies, you can conduct your research in consumer research, customer satisfaction research, market research, public opinion research and many other categories. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. This news release contains forward-looking statements. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca. Both Cedar Psychiatry and Cedar Clinical Research are wholly owned subsidiaries of Novamind. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. The Company expects to file the Required Filings today, November 4, 2021.

If the cease trade order is revoked, the Company expects trading of the Company's common shares on the CSE to resume. If the Company files the Required Filings within 90 days of the date of the cease trade order, the filing of the Required Filings constitutes the Company's application to revoke the cease trade order. The delay in the filing of the Required Filings was due to the Company's auditor requiring more time to complete its audit procedures related to the Company's annual financial statements for the year ended June 30, 2021.As a result of the cease trade order, the Company's common shares are expected to be suspended from trading on the Canadian Securities Exchange ('CSE'). certification of the foregoing filings as required by National instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings.Psychedelics company Novamind recently announced that it raised 10 million. management's discussion and analysis relating to the audited financial statements for the year ended Jand See the 20-slide pitch deck a psychedelics startup used to raise funds to build out a network of ketamine clinics.audited annual financial statements for the year ended J.(CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ('Novamind' or the 'Company'), a leading mental health company specialized in psychedelic medicine, today announced that it is the subject of a failure-to-file cease trade order issued by the Ontario Securities Commission on Novemas a result of the Company's failure to timely file the following continuous disclosure documents (collectively, the ' Required Filings') by Octo(the ' Filing Deadline'): TORONTO, ON / ACCESSWIRE / Novem/ Novamind Inc.

Novamind kat.cr